LPL Financial
RKDA icon

LPL Financial’s Arcadia Biosciences RKDA Stock Holding History

LPL Financial’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,025
Closed -$11.1K – 4570
2022
Q4 		$11.1K Sell
1,025
-51
-5% -$726 ﹤0.01% 4410
2022
Q3 		$23K Hold
1,076
– – ﹤0.01% 4315
2022
Q2 		$43K Sell
1,076
-25
-2% -$1.15K ﹤0.01% 4254
2022
Q1 		$62K Hold
1,101
– – ﹤0.01% 4034
2021
Q4 		$46K Sell
1,101
-113
-9% -$7.37K ﹤0.01% 4240
2021
Q3 		$100K Buy
1,214
+103
+9% +$9.66K ﹤0.01% 4146
2021
Q2 		$132K Buy
1,111
+47
+4% +$5.12K ﹤0.01% 4004
2021
Q1 		$117K Buy
1,064
+395
+59% +$48.4K ﹤0.01% 3893
2020
Q4 		$68K Buy
669
+100
+18% +$12.2K ﹤0.01% 3715
2020
Q3 		$64K Buy
569
+182
+47% +$24.6K ﹤0.01% 3417
2020
Q2 		$58K Buy
+387
New +$60.2K ﹤0.01% 3343

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LPL Financial's RKDA Position: Q1 2023 in Review

LPL Financial sold out of Arcadia Biosciences (RKDA) in Q1 2023, closing a stake of 1,025 shares — an estimated $11.1K sold.

LPL Financial first reported a position in RKDA in Q2 2020 and held it in 11 quarters. The position peaked at $132K in Q2 2021. 15 funds tracked by Wall St. Rank hold RKDA as of Q1 2023.

  • LPL Financial reported no remaining Arcadia Biosciences position as of Q1 2023 after selling out during the quarter.
  • LPL Financial sold 1,025 Arcadia Biosciences shares in Q1 2023, an estimated $11.1K.
  • LPL Financial first reported a position in Arcadia Biosciences in Q2 2020 and held it in 11 quarters.
  • LPL Financial's Arcadia Biosciences position peaked at $132K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2023.

Based on LPL Financial's 13F filing for Q1 2023, filed 10 May 2023.